Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD3 | Q9NY59 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.48 |
| ▸ | RELA | Q04206 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31429578 | 0.86 | SMPD3 (0.54) | SMPD3NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL31429665 | 0.86 | GAA (0.37) | SMPD3NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL31429675 | 0.84 | SMPD3 (0.52) | SMPD3NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL31429633 | 0.84 | SMPD3 (0.52) | SMPD3NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL31429535 | 0.82 | SMPD3 (0.52) | SMPD3NPC1RAB9ASMN1; SMN2GAA | |
| SCHEMBL31429765 | 0.80 | SMPD3 (0.53) | SMPD3NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL31429576 | 0.77 | SMPD3 (0.43) | SMPD3NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL31429575 | 0.75 | SMPD3 (0.53) | SMPD3NPC1RAB9ASMN1; SMN2GAA | |
| SCHEMBL31429524 | 0.72 | PTGES (0.36) | SMPD3RAB9ASMN1; SMN2GAAKDM4E | |
| SCHEMBL31429664 | 0.72 | F2 (0.45) | SMPD3NPC1RAB9ANFKB1NFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109849-A1 | EPOXY RESIN COMPOSITION, RESIN PASTE, FILM-TYPE ADHESIVE, PRINTED WIRING BOARD, SEMICONDUCTOR CHIP PACKAGE, AND ELECTRONIC DEVICE | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| WO-2025121026-A1 | EPOXY RESIN COMPOSITION, RESIN PASTE, RESIN FILM, AND SEMICONDUCTOR DEVICE | 旭化成株式会社 | 2025-06-12 | — | — | WO | disclosed |
| CN-119894957-A | Epoxy resin composition, resin paste, film-type adhesive, printed circuit board, semiconductor chip package, and electronic device | 旭化成株式会社 | 2025-04-25 | — | — | CN | disclosed |
| WO-2025058018-A1 | COMPOUND | 旭化成株式会社 | 2025-03-20 | — | — | WO | disclosed |
| WO-2025009354-A1 | EPOXY RESIN COMPOSITION, RESIN PASTE, FILM-TYPE ADHESIVE, PRINTED WIRING BOARD, SEMICONDUCTOR CHIP PACKAGE, AND ELECTRONIC DEVICE | 旭化成株式会社 | 2025-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109849-A1 | EPOXY RESIN COMPOSITION, RESIN PASTE, FILM-TYPE ADHESIVE, PRINTED WIRING BOARD, SEMICONDUCTOR CHIP PACKAGE, AND ELECTRONIC DEVICE | ASH2L, DOT1L, ASH1L | SMPD3 4868/4885NPC1 4813/4885RAB9A 4543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.